Skip to main content
Home
About Us
Careers
Investors
Media Resources
Clinicians
Overview
Clinical Trials
Instructions for Use
Resources
Meetings & Events
Grant Requests
Patients & Caregivers
Overview
Current Treatment Options
What is a VAD?
Site Finder
Glossary of Terms
Products & Technology
Overview
Pump Design
Surgical Tools & Accessories
Electronics
Technology Pipeline
Investor Relations Home
Corporate Profile
Investor Fact Sheet
Share Price Information
ASX Announcements
SEC Filings
News Releases
Annual Reports
Corporate Presentations
Events Calendar
Corporate Governance
Shareholder Services
Analyst Coverage
Investor FAQs
Email Alerts
Contact Investor Relations
Print Page
Email Page
RSS Feeds
Email Alerts
IR Contacts
2013 ASX Announcements
Keyword Search
2013 |
2012
|
2011
|
2010
|
2009
Date
Title
05/21/13
ASX Appendix 3B - Options Vesting and Exercise
05/20/13
Change of Director's Interest Notices
05/17/13
HeartWare to Webcast Presentation at UBS Global Healthcare Conference
05/10/13
ASX Appendix 3B - Options vesting and exercise
05/07/13
First Quarter 2013 Financial Results
04/30/13
Reports 2013 Q1 Rev of US$49.2M vs US$26.4M in Q1 2012
04/22/13
ASX Appendix 3B - Options Vesting, Exercise and Cancellation
04/16/13
Notice of Annual General Meeting
04/02/13
ASX Appendix 3B - Options Exercise
03/27/13
ASX Appendix 3B - Options Vesting and Exercise
03/21/13
Change of Director's Interest Notice
03/19/13
HeartWare International, Inc. Announces Closing of Public Offering of Common Stock
03/19/13
Options Exercise - ASX Appendix 3B
03/19/13
Capital Raising - ASX Appendix 3B Allotment
03/19/13
Capital Raising - Cleansing Notice
03/15/13
ASX Appendix 3B - Options Exercise
03/15/13
Prospectus Supplement for Public Offering of Common Stock
03/14/13
Prospectus for Public Offering of HeartWare Common Stock
03/13/13
Pricing of Public Offering of Common Stock
03/12/13
HeartWare Announces Public Offering of Common Stock
03/11/13
ASX Appendix 3B - Grant and Cancellation of Options
03/11/13
ASX Appendix 3B - Options Grant
03/07/13
HeartWare to Webcast Presentation at Barclays Capital Global
03/01/13
HeartWare to Webcast Presentation at Raymond James Conference
02/28/13
Annual Report for 2012 and ASX Appendix 4E
02/28/13
Reports 2012 Revenue of US$110.9M vs US$82.8M in 2011
02/19/13
Notice of Fourth Quarter Financial Results Call
02/18/13
Grant of Incentive Equity - ASX Appendix 3B
02/11/13
HeartWare to webcast presentation at Leerink Swann Global Healthcare Conference to be webcast
02/11/13
HeartWare Initiates Voluntary Field Correction Advising Insp
01/23/13
Amended Change of Director's Interest Notice
01/22/13
Change of Director's Interest Notice
01/16/13
ASX Appendix 3B
01/10/13
ASX Appendix 3B - Grant and Cancellation of Options
01/08/13
HeartWare Announces Preliminary Q4 2012 Revenues of US$32Mil
01/04/13
HeartWare to Webcast Presentation at JP Morgan Healthcare Co
01/04/13
Amended Change of Director's Interest Notice
01/02/13
ASX Appendix 3B - Options Exercise and Vesting
01/02/13
Change of Director's Interest Notice